NAPO - Novel Approach for Oligospermia

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

January 29, 2025

Study Completion Date

December 31, 2025

Conditions

Infertility, Male

Interventions

DRUG

Denosumab

Subcutaneous injection with 60 mg Denosumab once

DRUG

sodium chloride

Subcutaneous injection with NaCl once

Trial Locations (1)

Division of Translational Endocrinology, Department of Endocrinology and Internal Medicine, Copenhagen

All Listed Sponsors

lead

Martin Blomberg Jensen

OTHER